Alphabet's life science subsidiary Verily announced a strategic restructuring last year, shifting its focus to using AI and data science to improve precision health options.
Andrew Trister, chief medical and science officer at Verily, sat down with MobiHealthNews to discuss the company's use of AI technology, its work with tech giant Google and what excites him about the business's future....
Alphabet's life science subsidiary Verily's new CEO, Stephen Gillett, announced in an email to employees on Wednesday that it's laying off 15% of its staff due to the need to center its strategy, prioritize products and change its operating model.
Verily has over 1,600 employees, according to the Wall Street Journal, which first reported the layoffs, meaning more than 200 employees will be...
Google Cloud, health insurer Highmark Health and League, a platform that helps healthcare organizations and consumer health companies build digital tools, announced a partnership to build a digital health platform for Highmark members.
The My Highmark member portal provides the insurer's members with what the companies call a "digital front door," where they can navigate their care, pay bills,...
Coeus.health, a cloud-based IT and logistics platform that coordinates in-home digital health devices and data, announced its receipt of an initial investment from consumer electronics retailer Best Buy.
In its latest step to expand into the connected home healthcare space, the retail giant will use the remote patient monitoring (RPM) platform's Home Health Hybrid Cloud (H3C) to help customers...
San Diego-based connected sleep device maker ResMed and Alphabet's life science offshoot Verily announced the formation of Primasun, an end-to-end solution to help employers and healthcare providers identify populations at risk for complex sleep disorders.
Formed as a joint venture, Primasun will initially evaluate patients with insomnia, provide guidance to improve sleep hygiene and connect...
Alphabet's life science offshoot Verily announced it had raised $1 billion in an investment round led by its parent company alongside a shakeup of its executive team.
The company's founder Andy Conrad will step down as CEO, moving to an executive chairman position on Verily's board. Current president Stephen Gillett will take the reins in the chief executive role, effective January 2023.
Gillett...
iRhythm Technologies announced it has received another FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System that works with a wearable to monitor patients with atrial fibrillation, an irregular heart rhythm.
Developed in partnership with Alphabet life science subsidiary Verily, the ZEUS System is a platform that works with the Zio Watch to detect AFib, characterize the amount...
Alphabet's life-science subsidiary Verily is teaming up with cosmetics giant L'Oréal in an effort to better understand skin care and develop new digital tools in the dermatology space. The partners plan to study dermatological health over time to better understand the environment and aging's impact on skin and the "deep biology of the skin."
Verily's R&D team and L'Oréal's Active Cosmetic...
Diagnostic company Cue Health announced on Thursday that it will create an Omicron-genotyping COVID-19 test.
The test will be used in professional care settings to specifically detect the Omicron variant in nasal samples. The work is part of a partnership with HHS’ Biomedical Advanced Research and Development Authority (BARDA).
"An Omicron-specific test will assist clinicians in providing...
Google’s healthcare business looks a lot different at the end of 2021 compared with the beginning of the year.
The tech giant overhauled its strategy this year, eventually dismantling its health division. However, it still released a variety of tools for both consumers and clinicians, with a particular focus on healthcare accessibility and managing COVID-19 as the pandemic moved into its second...
